Rahul Banerjee
MD, FACP
Medicine
Hematology, Internal Medicine
Seattle, Washington, United States
Dr. Rahul Banerjee is a physician-researcher who specializes in bone marrow and blood stem cell transplantation as well as cellular immunotherapies for the treatment of blood cancers. He has a particular interest in multiple myeloma, which results in the overproduction of blood components of the immune system known as plasma cells.
Dr. Banerjee also treats patients with AL amyloidosis, a related but rarer condition that is treated similarly through close collaboration between cancer doctors, kidney doctors, and heart doctors. Those treatments may include transplantation using a reinfusion of a patient’s own blood stem cells or the use of CAR T cell therapies, where the patient’s stem cells are genetically modified to respond to the condition. In addition to novel treatments for multiple myeloma and AL amyloidosis, Dr. Banerjee's research interests involve digital health and supportive care to help patients as they undergo these treatments.
